Research Calls I
-
Upgrades
- Broadcom (AVGO) upgraded to Buy from Hold at Erste Group
- Dollar Tree (DLTR) upgraded to Overweight from Neutral at JPMorgan, tgt $111
- Dr. Reddy's (RDY) upgraded to Buy from Hold at HSBC, tgt $16.90
- Intuitive Surgical (ISRG) upgraded to Buy from Hold at Erste Group
- OGE Energy (OGE) upgraded to Overweight from Equal Weight at Barclays, tgt $47
- Southern Company (SO) upgraded to Buy from Hold at Jefferies, tgt $100
- Texas Instruments (TXN) upgraded to Market Perform from Underperform at Bernstein, tgt $180
- Udemy (UDMY) upgraded to Equal Weight from Underweight at Morgan Stanley, tgt $9
- Visa (V) upgraded to Outperform from Neutral at Mizuho, tgt $425
- Broadcom (AVGO) upgraded to Buy from Hold at Erste Group
-
Downgrades
- Chewy (CHWY) downgraded to Hold from Buy at Jefferies, tgt $43
- Coursera (COUR) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $11
- Eli Lilly (LLY) downgraded to Hold from Buy at Erste Group
- Ferguson (FERG) downgraded to Hold from Buy at Berenberg, tgt $215
- Hamilton Insurance (HG) downgraded to Market Perform from Outperform at BMO Capital, tgt $23
- Lavoro (LVRO) downgraded to Underperform from Outperform at Oppenheimer
- MercadoLibre (MELI) downgraded to Hold from Buy at Jefferies, tgt $2,800
- Salesforce (CRM) downgraded to Hold from Buy at Erste Group
- Chewy (CHWY) downgraded to Hold from Buy at Jefferies, tgt $43
-
Others
- CoreWeave (CRWV) initiated with a Neutral at Arete, tgt $130
- Excelerate Energy (EE) initiated with a Buy at Jefferies, tgt $39
- Funko (FNKO) initiated with a Buy at Texas Capital, tgt $8
- Kingsoft Cloud (KC) assumed with a Buy at UBS, tgt $14
- Marvell (MRVL) initiated with a Buy at China Renaissance
- Milestone Pharmaceuticals (MIST) assumed with a Buy at H.C. Wainwright, tgt $5
- Monopar Therapeutics (MNPR) initiated with a Buy at Lucid Capital, tgt $71
- Nebius Group (NBIS) initiated with a Buy at Arete, tgt $84
- Parker-Hannifin (PH) initiated with an Equal Weight at Morgan Stanley, tgt $700
- Phio Pharmaceuticals (PHIO) assumed with a Buy at H.C. Wainwright, tgt $14
- PolyPid (PYPD) initiated with a Buy at Roth Capital, tgt $9
- Telix Pharmaceuticals (TLX) initiated with an Outperform at Wedbush, tgt $22
- CoreWeave (CRWV) initiated with a Neutral at Arete, tgt $130